her2-low and her2-zero in breast cancer: prognosis & prediction | oncotarget
Published 4 months ago • 48 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:18
systemic treatment for brain metastasis in her2-positive advanced breast cancer | oncotarget
-
2:30
prognostic value of her2-low status in breast cancer: a systematic review and meta-analysis
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
2:14
clinical and molecular characteristics of her2-low/zero early stage triple-negative breast cancer
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
5:16
treatment options for her2-low breast cancer: all you need to know
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
1:33
questions remaining in the field of her2-low breast cancer
-
58:05
#breastpath destiny of her2/neu in the era of her2-low in 2024
-
0:54
destiny-breast06 trial in her2 low and her2 ultra low metastatic breast cancer.
-
1:40
her2-low is not a distinct subtype in inflammatory breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
13:09
get all the info you need about her2 ve breast cancer - her2 ve breast cancer || dr liz o'riordan
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
2:31
what is her2 low in breast cancer?
-
1:09
the exciting new field of her2-low breast cancer
-
11:12
her2-low breast cancer: destiny or good science?
-
7:13
overview of the management of her2-low breast cancer patients